Comprehensive AAV Bioassay Services for Gene Therapy Development

We deliver a comprehensive suite of AAV-based assays to support gene therapy development, preclinical studies, and translational research. Our services include pre-existing immunogenicity testing to evaluate baseline immune responses to AAV serotypes, biodistribution studies to assess vector spread and tissue targeting, and neutralization assays to measure antibody presence and potency that could impact therapeutic efficacy. Each assay is fully customizable to meet your specific study requirements, and our rigorous methodologies ensure reliable, high-quality data to accelerate vector optimization and support informed decision-making throughout the development process.